CN104984141A - 一种治疗便秘的方剂及其制备方法 - Google Patents
一种治疗便秘的方剂及其制备方法 Download PDFInfo
- Publication number
- CN104984141A CN104984141A CN201510452801.6A CN201510452801A CN104984141A CN 104984141 A CN104984141 A CN 104984141A CN 201510452801 A CN201510452801 A CN 201510452801A CN 104984141 A CN104984141 A CN 104984141A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- minutes
- minute
- constipation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010010774 Constipation Diseases 0.000 title claims abstract description 78
- 238000002360 preparation method Methods 0.000 title claims description 28
- 239000003814 drug Substances 0.000 claims abstract description 59
- 210000000582 semen Anatomy 0.000 claims abstract description 55
- 229940079593 drug Drugs 0.000 claims abstract description 29
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 71
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 239000000706 filtrate Substances 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- 241001428166 Eucheuma Species 0.000 claims description 25
- 239000008517 radix Trichosanthis Substances 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 22
- 241000903946 Clematidis Species 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 17
- -1 filter Substances 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 15
- 239000006187 pill Substances 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 14
- 239000012467 final product Substances 0.000 claims description 13
- 239000000052 vinegar Substances 0.000 claims description 12
- 235000021419 vinegar Nutrition 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 238000001291 vacuum drying Methods 0.000 claims description 10
- 206010013786 Dry skin Diseases 0.000 claims description 9
- 235000007164 Oryza sativa Nutrition 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000005325 percolation Methods 0.000 claims description 9
- 235000009566 rice Nutrition 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 241000219061 Rheum Species 0.000 claims description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 235000013547 stew Nutrition 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 2
- 241000209094 Oryza Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 20
- 208000024891 symptom Diseases 0.000 abstract description 13
- 208000002193 Pain Diseases 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 240000000530 Alcea rosea Species 0.000 abstract description 3
- 235000017334 Alcea rosea Nutrition 0.000 abstract description 3
- 235000017303 Althaea rosea Nutrition 0.000 abstract description 3
- 240000004980 Rheum officinale Species 0.000 abstract description 3
- 235000008081 Rheum officinale Nutrition 0.000 abstract description 3
- 241001075517 Abelmoschus Species 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 244000298903 Basella rubra Species 0.000 abstract 1
- 235000009380 Basella rubra Nutrition 0.000 abstract 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 abstract 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 abstract 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 abstract 1
- 241000601151 Clematis florida Species 0.000 abstract 1
- 241000206671 Gelidium amansii Species 0.000 abstract 1
- 241001131629 Lancea Species 0.000 abstract 1
- 235000003956 Luffa Nutrition 0.000 abstract 1
- 244000050983 Luffa operculata Species 0.000 abstract 1
- 244000137827 Rumex acetosa Species 0.000 abstract 1
- 235000005291 Rumex acetosa Nutrition 0.000 abstract 1
- 240000000890 Trichosanthes cucumeroides Species 0.000 abstract 1
- 235000018854 Trichosanthes cucumeroides Nutrition 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000007722 traditional medicinal effect Effects 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 19
- 239000000796 flavoring agent Substances 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 230000013872 defecation Effects 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 210000002429 large intestine Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 244000061458 Solanum melongena Species 0.000 description 3
- 235000002597 Solanum melongena Nutrition 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 239000010685 fatty oil Substances 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CFAFEJHONLMPQY-UHFFFAOYSA-N 2-(dimethylazaniumyl)ethanesulfonate Chemical compound CN(C)CCS(O)(=O)=O CFAFEJHONLMPQY-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003402 Arthropod sting Diseases 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 240000001879 Digitalis lutea Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- 241000219071 Malvaceae Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- NTWLPZMPTFQYQI-UHFFFAOYSA-N (3alpha)-olean-12-ene-3,23-diol Natural products C1CC(O)C(C)(CO)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C NTWLPZMPTFQYQI-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- NDYMQXYDSVBNLL-UHFFFAOYSA-N (9beta,10alpha,16alpha,23E)-25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)C=CC(C)(C)OC(=O)C)C(O)CC3(C)C1CC=C1C2C=C(O)C(=O)C1(C)C NDYMQXYDSVBNLL-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- INDVLXYUCBVVKW-RNWIMVDMSA-N 24-Methylene cholesterol Natural products O[C@@H]1CC=2[C@@](C)([C@H]3[C@H]([C@H]4[C@@](C)([C@@H]([C@@H](CCC(C(C)C)=C)C)CC4)CC3)CC=2)CC1 INDVLXYUCBVVKW-RNWIMVDMSA-N 0.000 description 1
- INDVLXYUCBVVKW-PXBBAZSNSA-N 24-methylenecholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCC(=C)C(C)C)[C@@]1(C)CC2 INDVLXYUCBVVKW-PXBBAZSNSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 235000009376 Basellaceae Nutrition 0.000 description 1
- 241000219300 Basellaceae Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FEUWBELGELLWPV-UHFFFAOYSA-N Glycerol sinapate Natural products COC1=C(O)C(OC)=CC(C=CC(=O)OCC(COC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)OC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)=C1 FEUWBELGELLWPV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- GCGBHJLBFAPRDB-UHFFFAOYSA-N Hederagenin Natural products CC1(C)CCC2(CCC3(C)C4CCC5C(C)(CO)C(O)CCC5(C)C4CC=C3C2C1)C(=O)O GCGBHJLBFAPRDB-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- INDVLXYUCBVVKW-UHFFFAOYSA-N Methylencholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=C)C(C)C)C1(C)CC2 INDVLXYUCBVVKW-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037508 Punctate keratitis Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000006504 Scorpion Stings Diseases 0.000 description 1
- GCGBHJLBFAPRDB-KCVAUKQGSA-N Scutellaric acid Natural products CC1(C)CC[C@@]2(CC[C@@]3(C)[C@@H]4CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2C1)C(=O)O GCGBHJLBFAPRDB-KCVAUKQGSA-N 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034002 defecation rhythm Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- RAYJUFCFJUVJBB-UHFFFAOYSA-N dihydrokaempferol Natural products OC1Oc2c(O)cc(O)cc2C(=O)C1c3ccc(O)cc3 RAYJUFCFJUVJBB-UHFFFAOYSA-N 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- PGOYMURMZNDHNS-MYPRUECHSA-N hederagenin Chemical compound C1C[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PGOYMURMZNDHNS-MYPRUECHSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 201000003827 punctate epithelial keratoconjunctivitis Diseases 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗便秘的方剂,由下列原料药制备而成,均为重量份:莱菔子8-12;白芍10-16;酸模7-11;兰石草9-13;无花果10-14;王瓜根7-13;五指山参9-16;落葵11-14;天茄子8-15;大黄6-12;铁线莲10-15;菘菜8-16;蜀葵花9-14;玉米须11-18;石花菜9-15;丝瓜子8-13。本发明的优良效果还表现在:本发明将传统药性与中药现代药理有机结合,遣药组方,增进疗效;服用方便,安全、无副作用;不仅具有温通散结,降逆宽肠、理气止痛的作用,具有标本兼治之功效。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种治疗便秘的方剂及其制备方法。
背景技术
便秘是指粪便在肠内滞留过久,秘结不通,排便周期延长,或周期不长,但粪质干结,排出艰难,或粪质不硬,虽有便意,但便而不畅的病症。日常摄取蔬菜或水果的纤维质和水份不足、缺少运动的生活方式或环境改变等,是常见的便秘原因,旅行、怀孕或饮食改变也会造成便秘,但一般大家容易忽略的是,便秘也可能代表身体发生严重的问题,除摄护腺癌及子宫颈癌,因大肠长肿瘤造成肠道狭窄,也常导致便秘。虽然短暂的便秘并不代表肠胃异常,但是若是便秘现象持续超过三周以上,则应该及早就医,尤其当发现个人解便习惯改变,如经常便秘改变成经常腹泻,或时常腹泻转变成时常便秘时,即需就医寻求便秘原因,千万不要置之不理,忽略身体发出的警讯。
《素问·灵兰秘典论》记载:“大肠者,传导之官,变化出焉。”大肠为传导之官,主大便之形成与排出,故便秘总因肠腑传导失常所致。中医认为,便秘大多数是由燥热伤津,劳倦内伤,肝气郁滞,久病不起,年老体衰所导致的大肠传导功能失调所引起的便秘是指粪便在肠道内滞留的时间过长,致使粪便的水分减少、粪质干硬、便量减少的情况。长期便秘会影响到脾胃的运行,导致大肠传导失常,产生大量毒素堆积,继而引发口臭、色斑、肠道不适等症状。治疗上以通下为原则,还应根据虚实寒热,分别随证变通处理。
申请公布号 CN 104116841 A(申请号 201410304432.1)的中国发明专利文献公开了一种治疗便秘的中药制剂,由以下重量份的原料药制备而成:熟地黄4 份、玄参7 份、当归8 份、川芎12 份、火麻仁12份、大黄2 份、核桃仁11 份、红花12 份。申请公布号 CN 104258053 A(申请号 201410585015.9)的中国发明专利文献公开了一种治疗便秘的中膏药,由以下重量配比的原料药制备而成:白芍3、玄参4、麦冬2、生地3、知母4、天花粉5、玫瑰花4、生甘草5、白术4、升麻3、柴胡4、川芎2、白药4、山药3、山萸肉2、茯苓4、泽泻3、丹皮4、芒硝5、白蜜4、木香2、乌药3、沉香4、槟榔5。申请公布号CN 104623263 A(申请号 201310565090.4)的中国发明专利文献公开了一种治疗便秘的中药,由以下重量配比的原料药制备而成:石膏28-32克,知母10-14克,麦冬28-32克,茯苓8-12克,萆薢13-17克,石韦13-17克,桑寄生13-17克,萹蓄18-22克,瞿麦13-17克,白术10-14克,人参12-16克。
西药以泻药为主,虽然能够快速有效缓解病情,但治标不治本,不易长期服用,且整体治疗效果不佳,副作用大等。中医注重身体的调理,固本培元,平衡身体湿热气血,不仅能彻底消除病灶,还能恢复脏腑功能,提高免疫力,优势显著。
发明内容
针对现有技术的不足,本发明的目的是提供一种制备简单、方便服用、安全有效的治疗便秘的方剂及其制备方法。该方剂疗效显著,无任何副作用。
本发明的技术方案是:
一种治疗便秘的方剂,由下列原料药制备而成,均为重量份:莱菔子8-12;白芍10-16;酸模7-11;兰石草9-13;无花果10-14;王瓜根7-13;五指山参9-16;落葵11-14;天茄子8-15;大黄6-12;铁线莲10-15;菘菜8-16;蜀葵花9-14;玉米须11-18;石花菜9-15;丝瓜子8-13。
优选的方案中,莱菔子9-11;白芍12-14;酸模8-10;兰石草10-12;无花果11-13;王瓜根9-11;五指山参11-14;落葵12-13;天茄子10-13;大黄8-10;铁线莲11.5-13.5;菘菜10-14;蜀葵花10.5-12.5;玉米须13-16;石花菜11-13;丝瓜子9.5-11.5。
更加优选的,莱菔子10;白芍13;酸模9;兰石草11;无花果12;王瓜根10;五指山参12.5;落葵12.5;天茄子11.5;大黄9;铁线莲12.5;菘菜12;蜀葵花11.5;玉米须14.5;石花菜12;丝瓜子10.5。
一种治疗便秘的方剂,将其制成药学上可接受的丸剂,制备方法如下:
(1)莱菔子研磨成细粉,置中药提取器中,加2-4倍量的75%的乙醇(优选加3倍量的75%的乙醇),加热回流提取两次,每次各提取10-24分钟(优选每次各提取17分钟),合并两次醇提液,过滤,滤液减压浓缩至70℃相对密度为1.25-1.28的稠膏,真空干燥得干膏粉,研细,备用;
(2)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎18-36分钟(优选文火慢煎27分钟),过滤,滤液备用;大黄切薄片,加15%的米醋拌匀,焖润13-17分钟(优选焖润15分钟),置炒制容器内文火加热炒干,取出放凉,备用;
(3)将步骤(2)处理后的大黄与白芍、酸模、兰石草、无花果、王瓜根、落葵、天茄子、铁线莲、菘菜、蜀葵花和丝瓜子置于砂锅内,加35-45℃的清水没过药面(优选加40℃的清水没过药面),浸泡25-45分钟(优选浸泡35分钟),然后大火加热煮沸,转小火煎煮三次,每次各煎煮19-31分钟(优选每次各煎煮25分钟),合并三次煎液,过滤,滤液与步骤(2)所得滤液合并;
(4)将上述滤液减压浓缩至85℃相对密度为1.30-1.33的稠膏,喷雾干燥得干膏粉,研细,与步骤(1)所得干膏粉混合,以醇泛丸,制成梧桐子大小的丸剂,即得。
上述一种治疗便秘的丸剂的制备方法,优选的方案是,步骤(1)中真空干燥的温度为76-88℃(优选的真空干燥的温度为80-84℃,更加优选的真空干燥的温度为82℃)。
上述一种治疗便秘的丸剂的制备方法,优选的方案是,步骤(3)中大火加热煮沸6-14分钟(优选的大火加热煮沸8-12分钟,更加优选的大火加热煮沸10分钟)。
所述颗粒剂的服用方法是:
(1)兰石草、无花果、落葵、铁线莲、菘菜和蜀葵花置于热风干燥机中,于75℃干燥22-38分钟(优选于75℃干燥30分钟),然后于48℃干燥1-2小时(优选于48℃干燥1.5小时),取出,趁热粉碎成细粉,备用;丝瓜子、王瓜根和莱菔子置于黄酒中浸泡3-5小时(优选置于黄酒中浸泡4小时),取出沥干,然后文火加热翻炒至表面略有焦斑,取出,研磨成细粉,备用
(2)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎18-36分钟(优选文火慢煎27分钟),过滤,滤液备用;
(3)将白芍、酸模、天茄子和大黄粉碎成细粉,置于渗漉筒内,以乙醇和水为溶剂(乙醇和水体积比为2:3),按照渗漉法进行渗漉,待搜集的渗漉液澄清透明时,停止渗漉,过滤,回收乙醇,滤液与步骤(2)所得滤液合并,减压浓缩成稠膏,备用;
(4)向上述稠膏中加入步骤(1)处理后的原料药粉,加入辅料,搅拌使之混合均匀,置于制粒机中制成颗粒,干燥,过四号筛,包装,即得。
上述一种治疗便秘的颗粒剂的制备方法,优选的方案是,步骤(4)中所述辅料为质量分数为10%的糊精和质量分数为6%的微晶纤维素。
所述片剂的制备方法是:
(1)取大黄片,用10%-20%的米醋拌匀(优选用15%的米醋拌匀),焖12-20分钟(优选焖16分钟),文火加热炒干,取出放凉,捣碎成细粉备用;玉米须打碎,置坩埚内,在无烟的炉火中煅红透,倒入醋盆内淬酥,捞出干燥,捣碎成细粉,备用;
(2)五指山参、无花果、王瓜根、莱菔子和丝瓜子置于烘箱中于60-80℃干燥40-60分钟(优选于70℃干燥50分钟),干燥过程中保证逐渐升温,确保药材内部水分完全蒸发,然后置于万能粉碎机中粉碎成细粉,备用;
(3)将除步骤(1)和(2)以外的原料药置于砂锅内,加冷水没过药面并浸泡2-3小时(优选加冷水没过药面并浸泡2.5小时),然后文火慢煎三次,第一次煎煮32-40分钟(优选第一次煎煮36分钟),第二次和第三次各煎煮18-30分钟(优选第二次和第三次各煎煮24分钟),合并三次煎液,过滤,滤液减压蒸馏成稠膏,干燥得干膏细粉,冷却,备用;
(4)将步骤(1)-(3)处理后的原料药粉混合,加入硬脂酸镁和糊精细粉,机械拌匀,干燥,过110-130目筛(优选过120目筛),置于压片机中压成片剂,即得。
所述水剂的制备方法是:
(1)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎18-36分钟(优选文火慢煎27分钟),过滤,滤液备用;
(2)先将蜂蜜置锅内,加热至沸,加入大黄片(大黄:蜂蜜=6:1),文火炒至不粘手为度,取出放凉,备用;取白芍片,加黄酒拌匀(白芍:黄酒=10:1),焖18-30分钟(优选焖24分钟),文火炒至微黄,取出放凉,备用;
(3)将除步骤(1)和(2)以外的原料药置于药锅中,加清水于室温下浸泡1-2小时(优选加清水于室温下浸泡1.5小时),武火加热至沸,同时加入步骤(2)处理后的原料药,转文火煎煮三次,第一次煎煮28-40分钟(优选第一次煎煮34分钟),第二次煎煮15-25分钟(优选第二次煎煮20分钟),第三次煎煮8-16分钟(优选第三次煎煮12分钟),合并三次煎液,过滤,滤液与步骤(1)所得滤液合并,备用;
(4)将上述滤液减压浓缩至原体积的1/2,灭菌,冷却,灌装,即得。
本发明组方科学,制备方法简单,服用方便、效果显著。除此之外,本发明的优良效果还表现在:
1、本发明将传统药性与中药现代药理有机结合,遣药组方,增进疗效;服用方便,安全、无副作用;
2、本中药不仅具有温通散结,降逆宽肠、理气止痛的作用,具有标本兼治之功效。
3、本发明药源易得,药材成本低廉,疗效确切,具有较高的推广价值。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1 一种治疗便秘的方剂,由下列原料药制备而成,均为重量份(50g/份):莱菔子8份;白芍10份;酸模7份;兰石草9份;无花果10份;王瓜根7份;五指山参9份;落葵11份;天茄子8份;大黄6份;铁线莲10份;菘菜8份;蜀葵花9份;玉米须11份;石花菜9份;丝瓜子8份。
一种治疗便秘的丸剂的制备方法是:
(1)莱菔子研磨成细粉,置中药提取器中,加3倍量的75%的乙醇,加热回流提取两次,每次各提取17分钟,合并两次醇提液,过滤,滤液减压浓缩至70℃相对密度为1.25-1.28的稠膏,76℃真空干燥得干膏粉,研细,备用;
(2)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎27分钟,过滤,滤液备用;大黄切薄片,加15%的米醋拌匀,焖润15分钟,置炒制容器内文火加热炒干,取出放凉,备用;
(3)将步骤(2)处理后的大黄与白芍、酸模、兰石草、无花果、王瓜根、落葵、天茄子、铁线莲、菘菜、蜀葵花和丝瓜子置于砂锅内,加40℃的清水没过药面,浸泡35分钟,然后大火加热煮沸6分钟,转小火煎煮三次,每次各煎煮25分钟,合并三次煎液,过滤,滤液与步骤(2)所得滤液合并;
(4)将上述滤液减压浓缩至85℃相对密度为1.30-1.33的稠膏,喷雾干燥得干膏粉,研细,与步骤(1)所得干膏粉混合,以醇泛丸,制成梧桐子大小的丸剂,即得。
本发明所得丸剂的服用方法是:每天三次,每次8-10丸,温水送服,7天一个疗程。
典型病例:王XX,男,36岁,公司职员。患者于2011年9月16日来我院就诊。患者自述:一个月前出现便秘症状,有时三天才排便一次,有时两天排便一次,排便前下腹疼痛,但便后症状缓解。排便困难,排不干净。服用助排便药物后,可顺利排出,但停药后则出现便秘症状。检查:患者大便干涩,排出困难,四肢不温,小便清长,伴口臭、食欲不振症状,舌淡,苔白,脉沉迟。
服用本实施例所得一种治疗便秘的丸剂,服用方法:每天三次,每次8-10丸,温水送服,7天一个疗程。服用一个疗程后,患者便秘症状明显缓解,大便变软,小便正常;继续服用两个疗程后,患者便秘症状完全消失,排便正常,诸症解除,随访半年,患者身体健康,无复发。
实施例2 一种治疗便秘的方剂,由下列原料药制备而成,均为重量份(30g/份):莱菔子12份;白芍16份;酸模11份;兰石草13份;无花果14份;王瓜根13份;五指山参16份;落葵14份;天茄子15份;大黄12份;铁线莲15份;菘菜16份;蜀葵花14份;玉米须18份;石花菜15份;丝瓜子13份。
一种治疗便秘的颗粒剂的制备方法是:
(1)兰石草、无花果、落葵、铁线莲、菘菜和蜀葵花置于热风干燥机中,于75℃干燥30分钟,然后于48℃干燥1.5小时,取出,趁热粉碎成细粉,备用;丝瓜子、王瓜根和莱菔子置于黄酒中浸泡4小时,取出沥干,然后文火加热翻炒至表面略有焦斑,取出,研磨成细粉,备用
(2)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎27分钟,过滤,滤液备用;
(3)将白芍、酸模、天茄子和大黄粉碎成细粉,置于渗漉筒内,以乙醇和水为溶剂(乙醇和水体积比为2:3),按照渗漉法进行渗漉,待搜集的渗漉液澄清透明时,停止渗漉,过滤,回收乙醇,滤液与步骤(2)所得滤液合并,减压浓缩成稠膏,备用;
(4)向上述稠膏中加入步骤(1)处理后的原料药粉,加入辅料(辅料为质量分数为10%的糊精和质量分数为6%的微晶纤维素),搅拌使之混合均匀,置于制粒机中制成颗粒,干燥,过四号筛,包装,即得。
本发明所得颗粒剂的服用方法是:每天三次,每次20g,温水冲服,7天一个疗程。
实施例3 一种治疗便秘的方剂,由下列原料药制备而成,均为重量份(45g/份):莱菔子9份;白芍12份;酸模8份;兰石草10份;无花果11份;王瓜根9份;五指山参11份;落葵12份;天茄子10份;大黄8份;铁线莲11.5份;菘菜10份;蜀葵花10.5份;玉米须13份;石花菜11份;丝瓜子9.5份。
一种治疗便秘的片剂的制备方法是:
(1)取大黄片,用15%的米醋拌匀,焖16分钟,文火加热炒干,取出放凉,捣碎成细粉备用;玉米须打碎,置坩埚内,在无烟的炉火中煅红透,倒入醋盆内淬酥,捞出干燥,捣碎成细粉,备用;
(2)五指山参、无花果、王瓜根、莱菔子和丝瓜子置于烘箱中于70℃干燥50分钟,干燥过程中保证逐渐升温,确保药材内部水分完全蒸发,然后置于万能粉碎机中粉碎成细粉,备用;
(3)将除步骤(1)和(2)以外的原料药置于砂锅内,加冷水没过药面并浸泡2.5小时,然后文火慢煎三次,第一次煎煮36分钟,第二次和第三次各煎煮24分钟,合并三次煎液,过滤,滤液减压蒸馏成稠膏,干燥得干膏细粉,冷却,备用;
(4)将步骤(1)-(3)处理后的原料药粉混合,加入硬脂酸镁和糊精细粉,机械拌匀,干燥,过120目筛,置于压片机中压成片剂,即得。
本发明所得片剂的服用方法是:每天三次,每次4-5片,温水送服,7天一个疗程。
典型病例:苏XX,女,52岁,教师。患者于2012年6月3日来我院就诊。患者自述:因近一个月工作较为繁忙,饮食无规律,睡眠质量差,开始出现便秘症状,以前一天或者两天排便一次,现在三天才排便一次,且大便干,难以排出。多喝水或改善饮食后便秘症状未得到缓解,服泻药可勉强排出烂便。便秘已经严重影响到正常的工作和生活。后来了解到我院治疗便秘疗效显著,患者抱着试试看的态度来我院检查治疗。检查:患者大便秘结,小便涩难出,唇甲色淡,面色苍白,心急易惊,头晕目眩,舌淡,苔薄白,脉细。
服用本实施例所得一种治疗便秘的片剂,服用方法:每天三次,每次4-5片,温水送服,7天一个疗程。用药两个疗程后,患者诸症明显减轻,头晕目眩症状消失,大便变软,排便时间恢复正常;继续用药一个疗程加以巩固,患者痊愈。停药三个月后回访,无复发。
实施例4 一种治疗便秘的方剂,由下列原料药制备而成,均为重量份(35g/份):莱菔子11份;白芍14份;酸模10份;兰石草12份;无花果13份;王瓜根11份;五指山参14份;落葵13份;天茄子13份;大黄10份;铁线莲13.5份;菘菜14份;蜀葵花12.5份;玉米须16份;石花菜13份;丝瓜子11.5份。
一种治疗便秘的水剂的制备方法是:
(1)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎27分钟,过滤,滤液备用;
(2)先将蜂蜜置锅内,加热至沸,加入大黄片(大黄:蜂蜜=6:1),文火炒至不粘手为度,取出放凉,备用;取白芍片,加黄酒拌匀(白芍:黄酒=10:1),焖24分钟,文火炒至微黄,取出放凉,备用;
(3)将除步骤(1)和(2)以外的原料药置于药锅中,加清水于室温下浸泡1.5小时,武火加热至沸,同时加入步骤(2)处理后的原料药,转文火煎煮三次,第一次煎煮34分钟,第二次煎煮20分钟,第三次煎煮12分钟,合并三次煎液,过滤,滤液与步骤(1)所得滤液合并,备用;
(4)将上述滤液减压浓缩至原体积的1/2,灭菌,冷却,灌装,即得。
本发明所得水剂的服用方法是:每天三次,每次150-180mL,温热服用,7天一个疗程。
实施例5 一种治疗便秘的方剂,由下列原料药制备而成,均为重量份(40g/份):莱菔子10份;白芍13份;酸模9份;兰石草11份;无花果12份;王瓜根10份;五指山参12.5份;落葵12.5份;天茄子11.5份;大黄9份;铁线莲12.5份;菘菜12份;蜀葵花11.5份;玉米须14.5份;石花菜12份;丝瓜子10.5份。
一种治疗便秘的丸剂的制备方法是:
(1)莱菔子研磨成细粉,置中药提取器中,加3倍量的75%的乙醇,加热回流提取两次,每次各提取17分钟,合并两次醇提液,过滤,滤液减压浓缩至70℃相对密度为1.25-1.28的稠膏,82℃真空干燥得干膏粉,研细,备用;
(2)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎27分钟,过滤,滤液备用;大黄切薄片,加15%的米醋拌匀,焖润15分钟,置炒制容器内文火加热炒干,取出放凉,备用;
(3)将步骤(2)处理后的大黄与白芍、酸模、兰石草、无花果、王瓜根、落葵、天茄子、铁线莲、菘菜、蜀葵花和丝瓜子置于砂锅内,加40℃的清水没过药面,浸泡35分钟,然后大火加热煮沸10分钟,转小火煎煮三次,每次各煎煮25分钟,合并三次煎液,过滤,滤液与步骤(2)所得滤液合并;
(4)将上述滤液减压浓缩至85℃相对密度为1.30-1.33的稠膏,喷雾干燥得干膏粉,研细,与步骤(1)所得干膏粉混合,以醇泛丸,制成梧桐子大小的丸剂,即得。
本发明所得丸剂的服用方法是:每天三次,每次8-10丸,温水送服,7天一个疗程。
本发明所用主要中药原料的药理如下:
莱菔子:基原:为十字花科植物莱菔的成熟种子。化学成份:种子含脂肪油、挥发油。挥发油内有甲硫醇等。脂肪油中含多量芥酸、亚油酸、亚麻酸以及芥子酸甘油酯等。尚含有抗菌物质称莱菔素。性味:辛甘,平。归经:入肺、胃经。功能主治:下气定喘,消食化痰。治咳嗽痰喘,食积气滞,胸闷腹胀,下痢后重。
白芍:基原:本品为毛茛科植物芍药的干燥根。化学成份:根含芍药甙、牡丹酚、芍药花甙,苯甲酸约1.07%、挥发油、脂肪油、树脂、鞣质、糖、淀粉、粘液质、蛋白质、β-谷甾醇和三萜类。性味:苦、酸,微寒。归经:归肝、脾经。功效:平肝止痛,养血调经,敛阴止汗。主治:用于头痛眩晕,胁痛,腹痛,四肢挛痛,血虚萎黄,月经不调,自汗,盗汗。
酸模:基原:为蓼科植物酸模的根。化学成份:酸模根中含有大黄酚,大黄素甲醚,大黄素,大黄酚蒽酮,大黄素甲醚蒽酮,大黄素蒽酮,芦荟大黄素,8-O-β-D-葡萄糖基大黄酚,8-O-β-D-葡萄糖基大黄素,ω-乙酰氧基芦荟大黄素和酸模素。药理作用:1.毒性作用 因含酸性草酸钾及某些酒石酸,故有酸味,有时因草酸含量过多而致中毒,文献上曾有小儿食酸模叶而致死的报告。2.抗菌作用 其水提取物有抗真菌(发癣菌类)作用。性味:酸;微苦;性寒。功能主治:凉血止血;泄热通便;利尿;杀虫。主吐血;便血;月经过多;热痢;目赤;便秘;小便不通;淋浊;恶疮;疥癣;湿疹。
兰石草:基原:为玄参科植物肉果草的全草。化学成份:全草含葡萄糖,果糖,熊果酸,蔗糖,β-谷甾醇,芝麻素。性味:味甘;苦;性寒。归经:《高原中草药治疗手册》:“入肺,胃、大肠等经。”功能主治:清肺;排脓;解毒;消肿。主肺热咳嗽;肺痈;流感;痢疾;咽喉肿痛。
无花果:基原:为桑科植物无花果的干燥花托。药理作用:1.无花果含丰富的营养成分,供食用。在便秘时,可用作食物性轻泻剂。2.干果的水提取物经活性炭、丙酮处理后所得之物质有抗艾氏肉瘤的作用。3.从未成熟果实中所得的乳汁能抑制大鼠移植性肉瘤、小鼠自发性乳癌,致使肿瘤坏死;又能延缓移植性腺癌、骨髓性白血病、淋巴肉瘤之发展,使其退化。性味:甘;性凉。归经:肺;胃;大肠经。功能主治:清热生津;健脾开胃;解毒消肿。主咽喉肿痛;燥咳声嘶;乳汁稀少;肠热便秘;食欲不振;消化不良,泄泻痢疾;痈肿;癣疾。
王瓜根:基原:为菊科植物王瓜的种子。性味:味苦;性寒。归经:归大肠;胃经。功能主治:泻热通结;散瘀消肿。主热病烦渴;黄疸;热结便秘;小便不利;经闭;乳汁不下;症瘕;痈肿。
五指山参:基原:为锦葵科植物箭叶秋葵的根。性味:甘;淡;平。归经:肾;胃经。功能主治:滋阴润肺;和胃。主肺燥咳嗽;肺痨;胃痛;疳积;神经衰弱。
落葵:基原:落葵科落葵属植物落葵,以全草入药。性味:甘、淡,凉。归经:归心,肝,脾,大、小肠经。功能主治:清热解毒,接骨止痛。用于阑尾炎,痢疾,大便秘结,膀胱炎;外用治骨折,跌打损伤,外伤出血,烧烫伤。落葵中的黏滑物质是由水溶性果胶和黏蛋白等成分组成,而黏蛋白有抑制糖吸收的作用,可谓糖尿病患者的“福菜”。
天茄子:基原:为茄科植物紫花茄的果实、种子、叶。化学成份:天茄种子中含有麦角生物碱。药理作用:天茄种子生物碱成分对金黄色化脓微球菌、枯草芽胞杆菌、绿脓杆菌、大肠杆菌等有较强的抗细菌、真菌活性。性味:苦;寒。功能主治:泻下;解蛇毒。主大便秘结;毒蛇咬伤。
大黄:基原:为蓼科植物掌叶大黄、唐古特大黄或药用大黄的根茎。性味:苦,寒。归经:入胃、大肠、肝经。功能主治:泻热毒,破积滞,行瘀血。治实热便秘,谵语发托,食积痞满,痢疾初起,里急后重,瘀停经闭,症瘕积聚,时行热疫,暴眼赤痛,吐血,衄血,阳黄,水肿,淋浊,溲亦,痈疡肿毒,疔疮,汤火伤。
铁线莲:基原:毛茛科铁线莲属植物铁线莲,以根及全草入药。化学成份: 根含常春藤皂甙元。性味: 味苦;微辛;性温;小毒。归经: 归肝;脾;肾经。功能主治: 利尿;通络;理气通便;解毒。主主治风湿性关节炎;小便不利;闭经;便秘腹胀;风火牙痛;眼起星翳;虫蛇咬伤;黄疸。
菘菜:基原:为十字花科植物青菜的叶。化学成份:嫩茎、叶含蛋白质,脂肪,糖类,粗纤维,钙磷,铁,胡罗卜素,核黄素,烟酸,维生素C。性味:甘;凉。归经:肠;胃经。功能主治:解热除烦;生津止渴;清肺消痰;通利肠胃。主肺热咳嗽;便秘;消渴;食积;丹毒;漆疮。
蜀葵花:基原:为锦葵科植物蜀葵的花。化学成份:花含1-对-羟基苯基-2-羟基-3-(2,4,6)-三羟基苯基一1,3-丙二酮,二氢山柰酚葡萄糖甙及蜀葵甙。鉴别:理化鉴别 取租粉1g,加2%盐酸甲醇溶液5ml浸渍20min,滤过,滤液显紫红色;取滤液滴于白瓷板内,滴加硫酸,显橙黄色。性味:甘;咸;凉。归经:肺;大肠;膀胱经。功能主治:和血止血;解毒散结。主吐血;衄血;有经过多;赤白带下;二便不通;小儿风疹;疟疾;痈疽疖肿;蜂蝎螫伤;烫伤;火伤。
玉米须:基原:为禾本科植物玉蜀黍的花柱。化学成份:含脂肪油2.5%、挥发油0.12%、树胶样物质3.8%、树脂2.7%、苦味糖甙1.15%、皂甙3.18%、生物碱O.05%。还含隐黄素、抗坏血酸、泛酸、肌醇、维生素K、谷甾醇、豆甾醇、苹果酸、柠檬酸、酒石酸、草酸等。药理作用:①利尿作用;②对循环系统的作用:麻醉犬静脉注射煎剂有显着降压作用;③降低血糖作用;④利胆、止血作用:性味:甘,平。归经:肾;胃;肝;胆经。功能主治:利尿,泄热,平肝,利胆。治肾炎水肿,脚气,黄疸肝炎,高血压,胆囊炎,胆结石,糖尿病,吐血衄血,鼻渊,乳痈。
石花菜:基原:为红翎菜种植物琼枝的藻体。化学成份:1.石花菜 含琼脂糖,琼脂胶,牛磺酸,N,N-二甲基牛磺酸,24-亚甲基胆甾醇,胆碱,维生素,及抗病毒多糖。性味:甘;咸;寒;滑;无毒。归经:肝;肺经。功能主治:清热解毒;化瘀散结;缓下;驱蛔。主肠炎腹泻;肾盂肾炎;瘿瘤;肿瘤;痔疮出血;慢性便秘;蛔早症。
丝瓜子:基原:为葫芦科植物丝瓜和奥丝瓜的种子。药理作用:1、峻泻作用:剂量为7-10颗种子粉;服15-20粒可致呕吐、腹泻,30-40粒则致严重腹泻,其有效成分是喷瓜素。2、洋地黄样作用:种子所含有的皂甙,对蛙心有洋地黄样作用。性味:味苦;性寒。功能主治:清热;利水;通便;驱虫。主水肿;石淋;肺热咳嗽;肠风下血;痔漏;便秘;蛔虫病。
试验例1 本发明所得一种治疗便秘的方剂(实施例5)的临床应用:
1 资料和方法
1.1 一般资料
选取2009年7月-2013年10月我院收治的便秘患者共346例。其中男性143例,女性203例,年龄在17-66岁,平均年龄42.5±3.5岁,病程在3个月-3年。
1.2 治疗方法
所有患者随机分为实验组和对照组,两组患者在性别、年龄、病程等方面,经统计学处理差异无显著性意义(P>0.05),具有可比性。其中实验组组服用本发明所得药物,服用方法:每天三次,每次8-10丸,温水送服,7天一个疗程。共观察治疗三个疗程。对照组服用其他药物(如麻仁润肠丸、清肠通便胶囊、莫沙必利等常规药物)。
1.3 疗效判定标准
依据国家中医药管理局有关《中医病症诊断疗效标准》制定。治愈:排便时间及便质正常,其它症状完全消失;显效:便质明显改善,排便时间明显缩短,其特征症状消失或显著缓解;有效:排便时间缩短,大便干结有所减轻,排便欠通畅;无效:便秘症状无改善。
总有效率=(治愈例数+显效例数+有效例数)/总实验例数×100%。
1.4 治疗结果
两组患者的治疗结果如表1所示。
表1:实验组和对照组肠炎患者的治疗结果
治疗效果:实验组治愈159例(69.7%),显效46例(20.2%),有效20例(8.8%),无效3例(1.3%),总有效率为98.7%。对照组总有效率为78.8%,故实验组治疗效果明显优于对照组。
本发明由莱菔子、白芍、酸模、兰石草、无花果、王瓜根、五指山参、落葵、天茄子、大黄、铁线莲、菘菜和蜀葵花等共16味主要原料药制备而成。方中,莱菔子下气定喘,消食化痰;白芍平肝止痛,养血调经;酸模凉血止血,泄热通便;兰石草清肺,排脓,解毒;无花果清热生津,健脾开胃,解毒消肿;天茄子主治大便秘结;菘菜解热除烦,通利肠胃;石花菜清热解毒,化瘀散结;丝瓜子清热,利水,通便;诸药配伍,相得益彰,共奏扶正培本,温通散结,降逆宽肠之功。治疗三个疗程,实验组总有效率为98.7%,而对照组总有效率仅为78.8%。
应当指出的是,具体实施方式只是本发明比较有代表性的例子,显然本发明的技术方案不限于上述实施例,还可以有很多变形。本领域的普通技术人员,以本发明所明确公开的或根据文件的书面描述毫无异议的得到的,均应认为是本专利所要保护的范围。
Claims (10)
1.一种治疗便秘的方剂,其特征在于,由下列原料药制备而成,均为重量份:莱菔子8-12;白芍10-16;酸模7-11;兰石草9-13;无花果10-14;王瓜根7-13;五指山参9-16;落葵11-14;天茄子8-15;大黄6-12;铁线莲10-15;菘菜8-16;蜀葵花9-14;玉米须11-18;石花菜9-15;丝瓜子8-13。
2.如权利要求1所述的一种治疗便秘的方剂,其特征在于,由下列原料药制备而成,均为重量份:莱菔子9-11;白芍12-14;酸模8-10;兰石草10-12;无花果11-13;王瓜根9-11;五指山参11-14;落葵12-13;天茄子10-13;大黄8-10;铁线莲11.5-13.5;菘菜10-14;蜀葵花10.5-12.5;玉米须13-16;石花菜11-13;丝瓜子9.5-11.5。
3.如权利要求1所述的一种治疗便秘的方剂,其特征在于,由下列原料药制备而成,均为重量份:莱菔子10;白芍13;酸模9;兰石草11;无花果12;王瓜根10;五指山参12.5;落葵12.5;天茄子11.5;大黄9;铁线莲12.5;菘菜12;蜀葵花11.5;玉米须14.5;石花菜12;丝瓜子10.5。
4.如权利要求1-3所述的一种治疗便秘的方剂,其特征在于,将其制成药学上可接受的丸剂,制备方法如下:
(1)莱菔子研磨成细粉,置中药提取器中,加2-4倍量的75%的乙醇(优选加3倍量的75%的乙醇),加热回流提取两次,每次各提取10-24分钟(优选每次各提取17分钟),合并两次醇提液,过滤,滤液减压浓缩至70℃相对密度为1.25-1.28的稠膏,真空干燥得干膏粉,研细,备用;
(2)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎18-36分钟(优选文火慢煎27分钟),过滤,滤液备用;大黄切薄片,加15%的米醋拌匀,焖润13-17分钟(优选焖润15分钟),置炒制容器内文火加热炒干,取出放凉,备用;
(3)将步骤(2)处理后的大黄与白芍、酸模、兰石草、无花果、王瓜根、落葵、天茄子、铁线莲、菘菜、蜀葵花和丝瓜子置于砂锅内,加35-45℃的清水没过药面(优选加40℃的清水没过药面),浸泡25-45分钟(优选浸泡35分钟),然后大火加热煮沸,转小火煎煮三次,每次各煎煮19-31分钟(优选每次各煎煮25分钟),合并三次煎液,过滤,滤液与步骤(2)所得滤液合并;
(4)将上述滤液减压浓缩至85℃相对密度为1.30-1.33的稠膏,喷雾干燥得干膏粉,研细,与步骤(1)所得干膏粉混合,以醇泛丸,制成梧桐子大小的丸剂,即得。
5.根据权利要求4所述的一种治疗便秘的丸剂的制备方法,其特征在于,步骤(1)中真空干燥的温度为76-88℃(优选的真空干燥的温度为80-84℃,更加优选的真空干燥的温度为82℃)。
6.根据权利要求4所述的一种治疗便秘的丸剂的制备方法,其特征在于,步骤(3)中大火加热煮沸6-14分钟(优选的大火加热煮沸8-12分钟,更加优选的大火加热煮沸10分钟)。
7.如权利要求1-3所述的一种治疗便秘的方剂,其特征在于,将其制成药学上可接受的颗粒剂,制备方法如下:
(1)兰石草、无花果、落葵、铁线莲、菘菜和蜀葵花置于热风干燥机中,于75℃干燥22-38分钟(优选于75℃干燥30分钟),然后于48℃干燥1-2小时(优选于48℃干燥1.5小时),取出,趁热粉碎成细粉,备用;丝瓜子、王瓜根和莱菔子置于黄酒中浸泡3-5小时(优选置于黄酒中浸泡4小时),取出沥干,然后文火加热翻炒至表面略有焦斑,取出,研磨成细粉,备用
(2)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎18-36分钟(优选文火慢煎27分钟),过滤,滤液备用;
(3)将白芍、酸模、天茄子和大黄粉碎成细粉,置于渗漉筒内,以乙醇和水为溶剂(乙醇和水体积比为2:3),按照渗漉法进行渗漉,待搜集的渗漉液澄清透明时,停止渗漉,过滤,回收乙醇,滤液与步骤(2)所得滤液合并,减压浓缩成稠膏,备用;
(4)向上述稠膏中加入步骤(1)处理后的原料药粉,加入辅料,搅拌使之混合均匀,置于制粒机中制成颗粒,干燥,过四号筛,包装,即得。
8.根据权利要求7所述的一种治疗便秘的颗粒剂的制备方法,其特征在于,步骤(4)中所述辅料为质量分数为10%的糊精和质量分数为6%的微晶纤维素。
9.如权利要求1-3所述的一种治疗便秘的方剂,其特征在于,将其制成药学上可接受的片剂,制备方法如下:
(1)取大黄片,用10%-20%的米醋拌匀(优选用15%的米醋拌匀),焖12-20分钟(优选焖16分钟),文火加热炒干,取出放凉,捣碎成细粉备用;玉米须打碎,置坩埚内,在无烟的炉火中煅红透,倒入醋盆内淬酥,捞出干燥,捣碎成细粉,备用;
(2)五指山参、无花果、王瓜根、莱菔子和丝瓜子置于烘箱中于60-80℃干燥40-60分钟(优选于70℃干燥50分钟),干燥过程中保证逐渐升温,确保药材内部水分完全蒸发,然后置于万能粉碎机中粉碎成细粉,备用;
(3)将除步骤(1)和(2)以外的原料药置于砂锅内,加冷水没过药面并浸泡2-3小时(优选加冷水没过药面并浸泡2.5小时),然后文火慢煎三次,第一次煎煮32-40分钟(优选第一次煎煮36分钟),第二次和第三次各煎煮18-30分钟(优选第二次和第三次各煎煮24分钟),合并三次煎液,过滤,滤液减压蒸馏成稠膏,干燥得干膏细粉,冷却,备用;
(4)将步骤(1)-(3)处理后的原料药粉混合,加入硬脂酸镁和糊精细粉,机械拌匀,干燥,过110-130目筛(优选过120目筛),置于压片机中压成片剂,即得。
10.如权利要求1-3所述的一种治疗便秘的方剂,其特征在于,将其制成药学上可接受的水剂,制备方法如下:
(1)将五指山参、石花菜和玉米须置于药锅中,加纯净水没过药面3-4cm,然后文火慢煎18-36分钟(优选文火慢煎27分钟),过滤,滤液备用;
(2)先将蜂蜜置锅内,加热至沸,加入大黄片(大黄:蜂蜜=6:1),文火炒至不粘手为度,取出放凉,备用;取白芍片,加黄酒拌匀(白芍:黄酒=10:1),焖18-30分钟(优选焖24分钟),文火炒至微黄,取出放凉,备用;
(3)将除步骤(1)和(2)以外的原料药置于药锅中,加清水于室温下浸泡1-2小时(优选加清水于室温下浸泡1.5小时),武火加热至沸,同时加入步骤(2)处理后的原料药,转文火煎煮三次,第一次煎煮28-40分钟(优选第一次煎煮34分钟),第二次煎煮15-25分钟(优选第二次煎煮20分钟),第三次煎煮8-16分钟(优选第三次煎煮12分钟),合并三次煎液,过滤,滤液与步骤(1)所得滤液合并,备用;
(4)将上述滤液减压浓缩至原体积的1/2,灭菌,冷却,灌装,即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510452801.6A CN104984141A (zh) | 2015-07-29 | 2015-07-29 | 一种治疗便秘的方剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510452801.6A CN104984141A (zh) | 2015-07-29 | 2015-07-29 | 一种治疗便秘的方剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104984141A true CN104984141A (zh) | 2015-10-21 |
Family
ID=54296124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510452801.6A Pending CN104984141A (zh) | 2015-07-29 | 2015-07-29 | 一种治疗便秘的方剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104984141A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920170A (zh) * | 2016-05-27 | 2016-09-07 | 廖鲜芳 | 防止头发脱落的中药制剂 |
| CN113827635A (zh) * | 2021-08-31 | 2021-12-24 | 赵井文 | 一种通便中药组合物及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327848A (zh) * | 2001-06-29 | 2001-12-26 | 宋小存 | 一种治疗习惯性便秘的中药 |
| CN103191241A (zh) * | 2013-04-19 | 2013-07-10 | 新乡医学院 | 一种治疗便秘的中药 |
| CN104587312A (zh) * | 2015-02-15 | 2015-05-06 | 孙红梅 | 一种治疗便秘的中药组合物 |
-
2015
- 2015-07-29 CN CN201510452801.6A patent/CN104984141A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327848A (zh) * | 2001-06-29 | 2001-12-26 | 宋小存 | 一种治疗习惯性便秘的中药 |
| CN103191241A (zh) * | 2013-04-19 | 2013-07-10 | 新乡医学院 | 一种治疗便秘的中药 |
| CN104587312A (zh) * | 2015-02-15 | 2015-05-06 | 孙红梅 | 一种治疗便秘的中药组合物 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920170A (zh) * | 2016-05-27 | 2016-09-07 | 廖鲜芳 | 防止头发脱落的中药制剂 |
| CN113827635A (zh) * | 2021-08-31 | 2021-12-24 | 赵井文 | 一种通便中药组合物及其制备方法 |
| CN113827635B (zh) * | 2021-08-31 | 2022-04-01 | 赵井文 | 一种通便中药组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972338A (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
| CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN103301267A (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
| CN103463449A (zh) | 一种用于治疗痔疮的中药组合物及其制备方法和其应用 | |
| CN104984141A (zh) | 一种治疗便秘的方剂及其制备方法 | |
| CN104998197A (zh) | 一种用于治疗肝癌的中药组合物 | |
| CN104983886A (zh) | 治疗便秘的中药制剂及制备方法 | |
| CN104984237A (zh) | 一种中药组合物及其制备方法 | |
| CN104771553A (zh) | 治疗胃癌的健脾补肾制剂及制备方法 | |
| CN104173973A (zh) | 一种治疗痢疾的口服液及其制备方法 | |
| CN104352802A (zh) | 治疗慢性痢疾的中药组合物及制备方法 | |
| CN110101818A (zh) | 一种治疗糖尿病的中药 | |
| CN105770760A (zh) | 主治胃溃疡的制剂及其制备方法 | |
| CN105288166A (zh) | 一种用于甲状腺肿大的中药组合物及其制备方法 | |
| CN104800457A (zh) | 一种治疗胃癌的软坚散结剂及制法 | |
| CN104958596A (zh) | 疝气患者服用的中药组合物 | |
| CN104784401A (zh) | 治疗胃癌的中药制剂 | |
| CN104815267A (zh) | 治疗小儿食积的消食化积中药剂 | |
| CN104707003B (zh) | 治疗高血压、高血脂的中药胶囊 | |
| CN105288441A (zh) | 一种沙棘养胃中药组合物及其制备方法 | |
| CN104706866A (zh) | 一种治疗肠炎的中药制剂及制备方法 | |
| CN104800687A (zh) | 一种治疗小儿疳积的中药剂及其制备方法 | |
| TW202333761A (zh) | 用於預防、改善或緩和痰濕相關症狀之組合物 | |
| CN104623567A (zh) | 一种治疗乳腺癌的活血化瘀中药制剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: Longshan road 033000 Shanxi city of Lvliang province Lishi District No. 633 Hualong District 1 building 2-102 Applicant after: Zhang Guangquan Address before: 250000 Ji'nan, China Hi tech Zone, Shandong Chong Hua Road, No. 11 Applicant before: Zhang Guangquan |
|
| COR | Change of bibliographic data | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151021 |
|
| RJ01 | Rejection of invention patent application after publication |